Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CGBD | RPC |
|---|---|---|
| Price | $10.40 | $7.91 |
| Change today | ▼ 0.95% | ▼ 0.75% |
| Market cap | $715.57M | $871.99M |
| Return, 3 months | +3.5% | +3.7% |
| Return, year to date | -7.9% | -18.2% |
| Return, 1 year | -1.8% | -23.8% |
| P/E (TTM) | 20.4 | 33.0 |
| P/B | 0.7 | 2.4 |
| P/E percentile vs own 5y | 97th | 23rd |
| Dividend yield | 14.90% | 1.93% |
| Revenue growth (YoY, latest qtr) | -82.8% | +11.3% |
| Net profit growth (YoY) | -100.4% | +102.0% |
| Gross margin | – | 51.5% |
| Operating margin | – | 23.6% |
| Net margin | 76.0% | 8.7% |
| Return on equity | 3.2% | 7.8% |
| Analyst target vs. price | +5.8% | +64.3% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 34 | 50 |
| 30-day volatility | 21.0% | 29.4% |
| Max drawdown, 1 year | -17.2% | -38.0% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
